180 related articles for article (PubMed ID: 38143233)
1. Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations.
Ollivier L; Debbi K; To NH; Cailleteau A; Supiot S; Mervoyer A; Guimas V; Belkacémi Y
Cancer Radiother; 2024 Feb; 28(1):119-130. PubMed ID: 38143233
[TBL] [Abstract][Full Text] [Related]
2. Evolving role of radiation therapy for hematologic malignancies.
Lee CK
Hematol Oncol Clin North Am; 2006 Apr; 20(2):471-503. PubMed ID: 16730303
[TBL] [Abstract][Full Text] [Related]
3. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Specht L
Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
[TBL] [Abstract][Full Text] [Related]
4. Hematologic Malignancies.
Tseng YD; Ng AK
Hematol Oncol Clin North Am; 2020 Feb; 34(1):127-142. PubMed ID: 31739939
[TBL] [Abstract][Full Text] [Related]
5. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT).
Yahalom J
Eur J Haematol Suppl; 2005 Jul; (66):90-7. PubMed ID: 16007875
[TBL] [Abstract][Full Text] [Related]
6. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.
Franklin J; Eichenauer DA; Becker I; Monsef I; Engert A
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD008814. PubMed ID: 28901021
[TBL] [Abstract][Full Text] [Related]
7. Modern radiotherapeutic strategies in the management of lymphoma.
Ballas L
Future Oncol; 2015; 11(6):1011-20. PubMed ID: 25760980
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy of lymphomas.
Balosso J; Missohou F; Antoni D; Hennequin C; Mahé MA; Simon L; Demoor-Goldschmidt C
Cancer Radiother; 2022; 26(1-2):388-396. PubMed ID: 34953716
[TBL] [Abstract][Full Text] [Related]
9. Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma.
Tseng YD; Chen YH; Catalano PJ; Ng A
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):223-31. PubMed ID: 25835625
[TBL] [Abstract][Full Text] [Related]
10. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.
Pinnix CC; Smith GL; Milgrom S; Osborne EM; Reddy JP; Akhtari M; Reed V; Arzu I; Allen PK; Wogan CF; Fanale MA; Oki Y; Turturro F; Romaguera J; Fayad L; Fowler N; Westin J; Nastoupil L; Hagemeister FB; Rodriguez MA; Ahmed S; Nieto Y; Dabaja B
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):175-82. PubMed ID: 25863764
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin and non-Hodgkin lymphoma: local-regional radiation therapy after bone marrow transplantation.
Abrams RA; Liu PJ; Ambinder RF; Haulk TL; Korman LT; Herman MG; Jones RJ
Radiology; 1997 Jun; 203(3):865-70. PubMed ID: 9169718
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and Predictors of 30-Day Readmission in CAR-T Cell Therapy Recipients.
Sharma A; Singh V; Deol A
Transplant Cell Ther; 2023 Feb; 29(2):108.e1-108.e7. PubMed ID: 36371048
[TBL] [Abstract][Full Text] [Related]
13. [Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].
Kirova Y
Cancer Radiother; 2020 Jun; 24(3):194-195. PubMed ID: 32402596
[No Abstract] [Full Text] [Related]
14. A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma.
Gustavsson A; Osterman B; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):605-19. PubMed ID: 14596518
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of ¹⁸FDG-PET with CT coregistration for radiation treatment planning of lymphomas and other hematologic malignancies.
Terezakis SA; Schöder H; Kowalski A; McCann P; Lim R; Turlakov A; Gonen M; Barker C; Goenka A; Lovie S; Yahalom J
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):376-83. PubMed ID: 24726287
[TBL] [Abstract][Full Text] [Related]
16. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
Tsang RW; Campbell BA; Goda JS; Kelsey CR; Kirova YM; Parikh RR; Ng AK; Ricardi U; Suh CO; Mauch PM; Specht L; Yahalom J
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):794-808. PubMed ID: 29976492
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in CAR T-cell therapy for lymphoma in China.
Che Y; Sun X
Clin Transl Oncol; 2023 Oct; 25(10):2793-2800. PubMed ID: 37062016
[TBL] [Abstract][Full Text] [Related]
18. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
19. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
Specht L; Yahalom J; Illidge T; Berthelsen AK; Constine LS; Eich HT; Girinsky T; Hoppe RT; Mauch P; Mikhaeel NG; Ng A;
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):854-62. PubMed ID: 23790512
[TBL] [Abstract][Full Text] [Related]
20. Proton therapy in the management of lymphoma.
Ho CK; Flampouri S; Hoppe BS
Cancer J; 2014; 20(6):387-92. PubMed ID: 25415683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
